Clinical Trial: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity

U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559136) titled 'A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS9531 Injection in Adolescents With Obesity' on April 23.

Brief Summary: The aim of this trial is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of HRS9531 injection compared with placebo in adolescents with obesity

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Overweight and Obesity

Intervention: DRUG: HRS9531 injection；Placebo

Drug: HRS9531 injection; low dose Drug: Placebo

DRUG: HRS9531 injection；Placebo

Drug: HRS9531 injection; medium dose Drug: Placebo

DRUG: HRS9531 inje...